Clinical Trial Update: Study of COYA 302 for the Treatment of ALS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating COYA 302 for amyotrophic lateral sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• COYA 302

Snippet

Sponsor: Coya Therapeutics | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: RECRUITING